Diagnostics / Digital Health / Health Equity
American Heart Month
This February, AdvaMed is working with member companies and our global partners to raise awareness and highlight the ways medical technology helps those living with cardiovascular disease live healthier, happier lives.
News / Global & Trade / Medical Imaging
AdvaMed Statement on the Sale and Privatization of the Federal Helium Reserve
January 22, 2024
Scott Whitaker, President and CEO of AdvaMed, the Medtech Association, urged the White House to delay the sale and privatization of the Federal Helium Reserve until concerns about resulting supply chain disruptions are resolved.
News / Global & Trade
AdvaMed Statement on 14th Ministerial Meeting of the United States-India Trade Policy Forum
January 19, 2024
AdvaMed President and CEO Scott Whitaker released the following statement regarding the 14th Ministerial-level Trade Policy Forum held in New Delhi, India:
News / Global & Trade / Supply Chain
AdvaMed Commends Administration Investment in Domestic Semiconductor Chip Manufacturing
January 10, 2024
The investments being made in our domestic semiconductor chip manufacturing base under the CHIPS and Science Act are critical for the medtech industry and the millions of patients who rely on the life-saving devices the medtech industry develops.
Global & Trade
In times of crisis, the medtech industry stands as a pillar of strength, providing innovative solutions to address immediate needs and foster resilience. Discover a few NGOs that AdvaMed members can partner with to help make a positive impact around the world.
News / Diagnostics / Government & Legislative Affairs / VALID Act
In Comments to FDA, AdvaMed Maintains Support of Agency’s Authority to Regulate LDTs
December 12, 2023
Today, AdvaMedDx submitted comments in response to the Food and Drug Administration’s Proposed Rule: Medical Devices; Laboratory Developed Tests. AdvaMedDx is a division of AdvaMed representing companies that develop in vitro diagnostic (IVD) tests.
News / Diagnostics
AdvaMed Calls for Reauthorization of AIDS Relief Program
November 15, 2023
Today, AdvaMedDx, a division of AdvaMed representing manufacturers of innovative in vitro diagnostic tests, sent a letter urging Congressional leaders to prioritize the reauthorization of the President’s Emergency Plan for AIDS Relief (PEPFAR) program. PEPFAR funding lapsed at the end of the fiscal year 2023.
News / Global & Trade
AdvaMed leads Global Effort to Push Back on Lithium Battery Transport Restrictions
November 13, 2023
As the International Civil Aviation Organization (ICAO) Dangerous Goods Panel meets this week, AdvaMed, the Medtech Association, led a group of 24 global medtech organizations in expressing concerns about the panel’s proposed regulations on the transport of dangerous goods aboard aircraft.